165 related articles for article (PubMed ID: 25607530)
1. Clinical and tumor significance of tropomyosin-1 expression levels in renal cell carcinoma.
Wang J; Guan J; Lu Z; Jin J; Cai Y; Wang C; Wang F
Oncol Rep; 2015 Mar; 33(3):1326-34. PubMed ID: 25607530
[TBL] [Abstract][Full Text] [Related]
2. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
3. Silencing of the TPM1 gene induces radioresistance of glioma U251 cells.
Du HQ; Wang Y; Jiang Y; Wang CH; Zhou T; Liu HY; Xiao H
Oncol Rep; 2015 Jun; 33(6):2807-14. PubMed ID: 25873252
[TBL] [Abstract][Full Text] [Related]
4. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-21 is overexpressed in renal cell carcinoma.
Lv L; Huang F; Mao H; Li M; Li X; Yang M; Yu X
Int J Biol Markers; 2013 Jun; 28(2):201-7. PubMed ID: 23558936
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
[TBL] [Abstract][Full Text] [Related]
8. WWOX protein expression varies among RCC histotypes and downregulation of WWOX protein correlates with less-favorable prognosis in clear RCC.
Lin JT; Tzai TS; Liao CY; Wang JS; Wu TT; Wang HY; Wu CH; Yu CC; Lu PJ
Ann Surg Oncol; 2013 Jan; 20(1):193-9. PubMed ID: 22555346
[TBL] [Abstract][Full Text] [Related]
9. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.
Wang L; Huang T; Chen W; Gao X; Zhou T; Wu Z; Sun Y
Oncol Rep; 2012 Dec; 28(6):2043-8. PubMed ID: 22972438
[TBL] [Abstract][Full Text] [Related]
10. Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma.
Pan H; Gu L; Liu B; Li Y; Wang Y; Bai X; Li L; Wang B; Peng Q; Yao Z; Tang Z
PLoS One; 2017; 12(2):e0168900. PubMed ID: 28182650
[TBL] [Abstract][Full Text] [Related]
11. Identification of miR‑125a‑5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis.
Chen D; Li Y; Su Z; Yu Z; Yu W; Li Y; Gui Y; Yang S; Lai Y
Mol Med Rep; 2015 Feb; 11(2):1278-83. PubMed ID: 25370896
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
[TBL] [Abstract][Full Text] [Related]
13. Flotillin-1 expression in human clear-cell renal cell carcinoma is associated with cancer progression and poor patient survival.
Zhang Y; Li J; Song Y; Chen F; Pei Y; Yao F
Mol Med Rep; 2014 Aug; 10(2):860-6. PubMed ID: 24913320
[TBL] [Abstract][Full Text] [Related]
14. Sprouty2 is associated with prognosis and suppresses cell proliferation and invasion in renal cell carcinoma.
Li P; Tao L; Yang J; Cai H; Ju X; Li J; Shao P; Cao Q; Qin C; Meng X; Yin C
Urology; 2013 Jul; 82(1):253.e1-7. PubMed ID: 23688375
[TBL] [Abstract][Full Text] [Related]
15. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
[TBL] [Abstract][Full Text] [Related]
16. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
[TBL] [Abstract][Full Text] [Related]
17. Suppression of GLTSCR2 expression in renal cell carcinomas.
Cho YE; Lee HL; Lim SJ; Kim YW; Choe BK; Lee S; Park JH
Pathol Res Pract; 2016 Feb; 212(2):120-4. PubMed ID: 26724143
[TBL] [Abstract][Full Text] [Related]
18. Downregulated Expression of Tropomyosin 1 in Intrahepatic Cholangiocarcinoma: A Predictor of Recurrence and Prognosis.
Chen Y; Hong Z; Lu S; Zhang N; Rong G; Chang X; Liu Z; Bai W; Dong Z; Gao X; Zeng Z; Lu Y
Med Sci Monit; 2018 Nov; 24():7875-7882. PubMed ID: 30390420
[TBL] [Abstract][Full Text] [Related]
19. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
20. Reduced L/B/K alkaline phosphatase gene expression in renal cell carcinoma: plausible role in tumorigenesis.
Sharma U; Pal D; Singh SK; Kakkar N; Prasad R
Biochimie; 2014 Sep; 104():27-35. PubMed ID: 24909115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]